RUBY   $0.0899  -23.32% Market Open

Rubius Therapeutics Inc
Last Events:

2023-03-29 Trend pattern changed from нисходящий клин to канал.

2023-03-29 Signal in Stochastic changed from bullish reversal to bearish weakening. The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bearish weakening to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: down-crossing the middle level.

2023-03-29 Signal in RSI changed from bearish to bearish recovery. RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

2023-03-29 Trend pattern changed from канал to нисходящий клин.

2023-03-29 Signal in Stochastic changed from bearish weakening to bullish reversal. The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bearish to bearish weakening. Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: main and signal line crossing.

2023-03-29 Signal in RSI changed from bearish recovery to bearish. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: entrance to the overbought zone.


Current temperature: 3.76
ST: 0, Cor:

50-50 Year Forecast
Low with 48% probability: 0.05
Target: 1.00
High with 49% probability: 0.27
Analyst Recommendations:
Number of estimates 1
Target Price Mean 1.00
Mean unverified/preliminary 1.00 / 1.00
Target Price Low / High 1.00 / 1.00
Median / STD DEV 1.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd Sell Sell Sell
stoch Sell Sell Sell
ma20 Sell - -
ma50 - Sell -
ma100 Sell - -
Candlestick PatternFeb. 28, 2023 Three Stars -
ISIN US78116T1034
ceo Ms. Dannielle Appelhans
Website https://www.rubiustx.com
Rubius Therapeutics, Inc., a biopharmaceutical company, focuses on the development of red cell therapeutics for the treatment of cancer and autoimmune diseases. The company was formerly known as VL26, Inc and as changed its name to Rubius Therapeutics, Inc. in 2015. Rubius Therapeutics, Inc. was incorporated in 2013 and is based in Foxborough, Massachusetts.